TVTX Competitors & Alternatives
Compare Travere Therapeutics Inc with similar stocks in the same industry
Biotechnology
TVTX
Main Stock$56.29
Tradestie Score
54
Market Cap
$2.21B
Revenue Growth
0.6%
Analyst Upside
+3.7%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$25.75
|
$6.03B | - | 45 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$50.63
|
$6.02B | - | 50 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.94
|
$5.95B | - | 58 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$228.28
|
$5.92B | - | 51 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$55.01
|
$5.80B | 20.0 | 59 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$363.44
|
$5.20B | 49.0 | 59 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$57.03
|
$4.94B | - | 63 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$81.33
|
$4.93B | - | 53 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$74.11
|
$4.84B | - | 43 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
More TVTX Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry